Vendor, Ames, IA
Pathovacs Inc.
UEI GAEYBFGAB1N9, CAGE 5SAC3
1 award and $0 obligated between March 13, 2024 and March 13, 2024, 100% under full and open competition, against 11.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| W911QY20C0114Definitive Contract, March 13, 2024, Full and Open Competition After Exclusion of Sources, 11 offers | W6QK ACC-APGDepartment of the Army | Small Business Technology Transfer Effort Titled Novel Circulating RNA-BASED Markers as Diagnostic Biomarkers of Infectious Diseases.NAICS 541714, PSC AD25 | $0 |